VENUSREM — Venus Remedies Balance Sheet
0.000.00%
- IN₹4.19bn
- IN₹3.25bn
- IN₹6.01bn
- 97
- 75
- 82
- 98
Annual balance sheet for Venus Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2020 March 31st | C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 36.2 | 292 | 458 | 713 | 838 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 592 | 608 | 671 | 1,255 | 1,479 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,940 | 2,340 | 2,780 | 3,230 | 3,595 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,086 | 1,901 | 1,782 | 1,628 | 1,544 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 6,438 | 5,559 | 5,798 | 6,011 | 6,268 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,246 | 974 | 927 | 826 | 794 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 3,204 | 1,556 | 1,394 | 1,407 | 1,393 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 3,234 | 4,003 | 4,404 | 4,603 | 4,876 |
Total Liabilities & Shareholders' Equity | 6,438 | 5,559 | 5,798 | 6,011 | 6,268 |
Total Common Shares Outstanding |